glp-1 scam 🛑 ALERT 🛑 We've been made aware of a fraudulent advert using Obesity UK's name and logo to promote a product called Weight Loss Oral Solution. It falsely claims endorsements Woman Scammed by Online Ad

GLP1 agonists like Semaglutide, Liraglutide may increase risk of pancreatitis, gastroparesis and bowel obstruction US: Researchers at University of British Columbia have found in a new study that that use of glucagon-like peptide-1 agonists for weight loss compared with use of bupropion-naltrexone was associated with increased risk of pancreatitis, gastroparesis, and bowel obstruction but not biliary disease

GLP-1 receptors are expressed not just in the pancreas and stomach, but throughout the vagus nerve, the brain stem, and the hypothalamus

J Biotechnol 10(261):194206 Szczeklik K, Krzysciak W, Domagala-Rodacka R, Mach P, Darczuk D, Cibor D, Pytko-Polonczyk J, Rodacki T, Owczarek D (2016) Alterations in glutathione peroxidase and superoxide dismutase activities in plasma and saliva in relation to disease activity in patients with Crohns disease

Subcutaneous injection is the standard administration route for daily peptide protocols in both preclinical and clinical research